Jan 9 (Reuters) - An experimental drug from Sanofi SA and Regeneron Pharmaceuticals was found to be effective in lowering "bad" cholesterol even when administered once every four weeks, instead of every two weeks.


from Reuters: Most Read Articles http://ift.tt/1tSJZbM http://www.reuters.com
No comments:
Post a Comment